Efficacy of the Additional Neoadjuvant Chemotherapy to Concurrent Chemoradiotherapy for Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: a Bayesian Network Meta-analysis of Randomized Controlled Trials.
about
What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis.Significant benefits of adding neoadjuvant chemotherapy before concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis of randomized controlled trials.Comparison between nedaplatin and cisplatin plus docetaxel combined with intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma: a multicenter randomized phase II clinical trial.Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter studyInduction chemotherapy followed by concurrent chemoradiotherapy vs. concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.Is pretreatment Epstein-Barr virus DNA still associated with 6-year survival outcomes in locoregionally advanced nasopharyngeal carcinoma?The Effect of Adding Neoadjuvant Chemotherapy to Concurrent Chemoradiotherapy in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma and Undetectable Pretreatment Epstein-Barr Virus DNA.Neoadjuvant and Concurrent Chemotherapy Have Varied Impacts on the Prognosis of Patients with the Ascending and Descending Types of Nasopharyngeal Carcinoma Treated with Intensity-Modulated RadiotherapyFeasibility of concurrent chemoradiotherapy with high-dose cisplatin after induction TPF chemotherapy in head and neck cancer: a critical review of the literature and the experience of the European Institute of Oncology.Overexpression of the PSAT1 Gene in Nasopharyngeal Carcinoma Is an Indicator of Poor PrognosisPrognostic value of wait time in nasopharyngeal carcinoma treated with intensity modulated radiotherapy: a propensity matched analysis.Overexpression of Transient Receptor Protein Cation Channel Subfamily A Member 1, Confers an Independent Prognostic Indicator in Nasopharyngeal Carcinoma.Glutamate Decarboxylase 1 Overexpression as a Poor Prognostic Factor in Patients with Nasopharyngeal Carcinoma.Radiotherapy with neoadjuvant chemotherapy versus concurrent chemoradiotherapy for ascending-type nasopharyngeal carcinoma: a retrospective comparison of toxicity and prognosis.Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials.Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method.Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients with cervical nodal necrosis.Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma.Efficacy and safety of nimotuzumab with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma.Association of the neoadjuvant chemotherapy cycle with survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: a propensity-matched analysis.Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.Neoadjuvant chemotherapy with different dose regimens of docetaxel, cisplatin and fluorouracil (TPF) for locoregionally advanced nasopharyngeal carcinoma: a retrospective study.Practice patterns for the radical treatment of nasopharyngeal cancer by head and neck oncologists in the United Kingdom.Addition of 5-fluorouracil to docetaxel/cisplatin does not improve survival in locoregionally advanced nasopharyngeal carcinoma.Additional induction chemotherapy to concurrent chemotherapy and intensity-modulated radiotherapy with or without nimotuzumab in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis.Addition of chemotherapy to intensity-modulated radiotherapy does not improve survival in stage II nasopharyngeal carcinoma patients.Integrated Diagnostic Model That Incorporates Epstein-Barr Virus DNA, Imaging, and Nasal Endoscopy to Stratify Primary Tumor and Lymph Nodes in a Patient with N1 Nasopharyngeal Carcinoma: Multidisciplinary Management.Neoadjuvant Chemotherapy with Fluorouracil plus Nedaplatin or Cisplatin for Locally Advanced Nasopharyngeal Carcinoma: a Retrospective Study
P2860
Q31146986-FA30BB95-D70E-495B-9CDE-4BAFAB6C7C01Q33433507-3DED2F8A-CF76-4A1E-B1F3-3718B2ADE339Q33435906-08A0CE2D-F5D4-46C7-9844-C2B972ABF0A3Q33436774-BC680D3C-85AB-4742-AE27-6DD52826FB27Q33441222-AC24279A-EB3C-4519-9E26-1561E98D782BQ33702316-70CE85A2-8FC7-4CB2-999A-85A1F0071C79Q33752579-3F5D1C0E-EC5A-4D6B-BC45-8596031CD4D3Q36174879-52D98AF9-5C5B-4D82-9F87-75FBE97863A9Q36341166-6F3EA916-9AFD-4805-B80C-2D48E95A63CBQ37015716-4607B930-9FD8-4728-B321-625365E4637DQ37046770-A4FA37E4-83A0-47E9-8769-F31DAE04FD1EQ37067968-C07B2A0B-F715-46FC-A15E-54FE6557D3C8Q37290566-99362031-9E98-4157-B009-9A6039B7D547Q37681958-827E235F-75D3-4599-B487-5E4135A5A703Q38963962-50AD3B17-54B2-44AD-ADF2-8121A944B2C2Q39399738-AE1E376A-ADC1-41E9-B42C-AC30E2EAC9C7Q41846802-B206C56D-3E27-47FD-85D7-BAA3F39436A1Q42368029-A8B4F109-5556-4F08-941C-4FF876768515Q45357051-785ECB61-016F-426C-B17B-89253B3ECFE0Q47098637-C375C71E-43A1-433C-9491-01EA55226A31Q47099520-374DCD5E-63AB-4E20-A22E-3E2CCE369B87Q47142016-6C3C954D-485A-4BEB-8FAD-383E0A240DF3Q48185045-33539081-9722-4168-8B00-4B06179E7466Q48502128-B6072668-3797-4BE1-AB3A-491CE08B5860Q50311224-6C205172-5054-4885-8180-4AB75649EAC5Q55259880-02194979-DED5-4BEF-B6E2-9270043A1422Q55354926-FFC3E671-129E-44DB-A1AD-B5D7657BA32EQ58555640-F4F60FF8-7831-4480-9230-AFEFE936EBCA
P2860
Efficacy of the Additional Neoadjuvant Chemotherapy to Concurrent Chemoradiotherapy for Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: a Bayesian Network Meta-analysis of Randomized Controlled Trials.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Efficacy of the Additional Neo ...... Randomized Controlled Trials.
@ast
Efficacy of the Additional Neo ...... Randomized Controlled Trials.
@en
type
label
Efficacy of the Additional Neo ...... Randomized Controlled Trials.
@ast
Efficacy of the Additional Neo ...... Randomized Controlled Trials.
@en
prefLabel
Efficacy of the Additional Neo ...... Randomized Controlled Trials.
@ast
Efficacy of the Additional Neo ...... Randomized Controlled Trials.
@en
P2093
P2860
P356
P1433
P1476
Efficacy of the Additional Neo ...... Randomized Controlled Trials.
@en
P2093
Ai-Hua Lin
Yan-Ping Mao
Yu-Pei Chen
P2860
P304
P356
10.7150/JCA.11814
P577
2015-07-17T00:00:00Z